| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |